Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs
(2007) In Gene Therapy 14(17). p.1278-1286- Abstract
- Transduced deoxyribonucleoside kinases (dNK) can be used to kill recipient cells in combination with nucleoside prodrugs. The Drosophila melanogaster multisubstrate dNK (Dm-dNK) displays a superior turnover rate and has a great plasticity regarding its substrates. We used directed evolution to create Dm-dNK mutants with increased specificity for several nucleoside analogs (NAs) used as anticancer or antiviral drugs. Four mutants were characterized for the ability to sensitize Escherichia coli toward analogs and for their substrate specificity and kinetic parameters. The mutants had a reduced ability to phosphorylate pyrimidines, while the ability to phosphorylate purine analogs was relatively similar to the wild-type enzyme. We selected... (More)
- Transduced deoxyribonucleoside kinases (dNK) can be used to kill recipient cells in combination with nucleoside prodrugs. The Drosophila melanogaster multisubstrate dNK (Dm-dNK) displays a superior turnover rate and has a great plasticity regarding its substrates. We used directed evolution to create Dm-dNK mutants with increased specificity for several nucleoside analogs (NAs) used as anticancer or antiviral drugs. Four mutants were characterized for the ability to sensitize Escherichia coli toward analogs and for their substrate specificity and kinetic parameters. The mutants had a reduced ability to phosphorylate pyrimidines, while the ability to phosphorylate purine analogs was relatively similar to the wild-type enzyme. We selected two mutants, for expression in the osteosarcoma 143B, the glioblastoma U-87M-G and the breast cancer MCF7 cell lines. The sensitivities of the transduced cell lines in the presence of the NAs fludarabine (F-AraA), cladribine (CdA), vidarabine and cytarabine were compared to the parental cell lines. The sensitivity of 143B cells was increased by 470-fold in the presence of CdA and of U-87M-G cells by 435fold in the presence of F-AraA. We also show that a choice of the selection and screening system plays a crucial role when optimizing suicide genes by directed evolution. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/691942
- author
- Knecht, W. LU ; Rozpedowska, Elzbieta LU ; Le Breton, C. ; Willer, M. ; Gojkovic, Z. ; Sandrini, Michael LU ; Joergensen, T. ; Hasholt, L. ; Munch-Petersen, B. and Piskur, Jure LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- purines, nucleoside analogs, directed evolution, deoxyribonucleoside kinase, cancer gene therapy
- in
- Gene Therapy
- volume
- 14
- issue
- 17
- pages
- 1278 - 1286
- publisher
- Nature Publishing Group
- external identifiers
-
- wos:000248882800004
- scopus:34548150268
- pmid:17581598
- ISSN
- 0969-7128
- DOI
- 10.1038/sj.gt.3302982
- language
- English
- LU publication?
- yes
- id
- efcc76bd-ae89-45ff-8b94-ab96ce69e523 (old id 691942)
- date added to LUP
- 2016-04-01 12:16:05
- date last changed
- 2022-01-27 01:17:26
@article{efcc76bd-ae89-45ff-8b94-ab96ce69e523, abstract = {{Transduced deoxyribonucleoside kinases (dNK) can be used to kill recipient cells in combination with nucleoside prodrugs. The Drosophila melanogaster multisubstrate dNK (Dm-dNK) displays a superior turnover rate and has a great plasticity regarding its substrates. We used directed evolution to create Dm-dNK mutants with increased specificity for several nucleoside analogs (NAs) used as anticancer or antiviral drugs. Four mutants were characterized for the ability to sensitize Escherichia coli toward analogs and for their substrate specificity and kinetic parameters. The mutants had a reduced ability to phosphorylate pyrimidines, while the ability to phosphorylate purine analogs was relatively similar to the wild-type enzyme. We selected two mutants, for expression in the osteosarcoma 143B, the glioblastoma U-87M-G and the breast cancer MCF7 cell lines. The sensitivities of the transduced cell lines in the presence of the NAs fludarabine (F-AraA), cladribine (CdA), vidarabine and cytarabine were compared to the parental cell lines. The sensitivity of 143B cells was increased by 470-fold in the presence of CdA and of U-87M-G cells by 435fold in the presence of F-AraA. We also show that a choice of the selection and screening system plays a crucial role when optimizing suicide genes by directed evolution.}}, author = {{Knecht, W. and Rozpedowska, Elzbieta and Le Breton, C. and Willer, M. and Gojkovic, Z. and Sandrini, Michael and Joergensen, T. and Hasholt, L. and Munch-Petersen, B. and Piskur, Jure}}, issn = {{0969-7128}}, keywords = {{purines; nucleoside analogs; directed evolution; deoxyribonucleoside kinase; cancer gene therapy}}, language = {{eng}}, number = {{17}}, pages = {{1278--1286}}, publisher = {{Nature Publishing Group}}, series = {{Gene Therapy}}, title = {{Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs}}, url = {{http://dx.doi.org/10.1038/sj.gt.3302982}}, doi = {{10.1038/sj.gt.3302982}}, volume = {{14}}, year = {{2007}}, }